Published in:
Open Access
01-11-2012 | Meeting abstract
Mechanism of coordinated access to orphan drugs
Authors:
R DeRidder, C Adriaens, D Kleinermans, M Mortier, A Quanten, F Arickx
Published in:
Orphanet Journal of Rare Diseases
|
Special Issue 2/2012
Login to get access
Excerpt
Although the EU Council stated[
1] that “
All health systems in the EU aim to make provision,
which is patient-centered and responsive to individual need”, numerous sources show important and unacceptable differences in access to orphan drugs in the Member States of the European Union (EU COM[
2], EURORDIS[
3,
4], BE EU Presidency[
5,
8], EU Council[
6]). With this regard, in the context of the 2010 Belgian EU presidency initiative on ‘Innovation and Solidarity’ and within the framework of the process on corporate responsibility in the field of pharmaceuticals[
7], EU Commissioner Tajani launched the project Mechanism of Coordinated Access to Orphan Drugs. …
